Standout Papers

Complete revascularisation versus treatment of the culprit lesion only in patients with ST-segment e... 2015 2026 2018 2022 561
  1. Complete revascularisation versus treatment of the culprit lesion only in patients with ST-segment elevation myocardial infarction and multivessel disease (DANAMI-3—PRIMULTI): an open-label, randomised controlled trial (2015)
    Thomas Engstrøm, Henning Kelbæk et al. The Lancet

Immediate Impact

1 from Science/Nature 72 standout
Sub-graph 1 of 19

Citing Papers

Intravascular imaging-guided coronary drug-eluting stent implantation: an updated network meta-analysis
2024 Standout
From patterns to patients: Advances in clinical machine learning for cancer diagnosis, prognosis, and treatment
2023 Standout
8 intermediate papers

Works of Jens Aarøe being referenced

Differential clinical outcomes after 1 year versus 5 years in a randomised comparison of zotarolimus-eluting and sirolimus-eluting coronary stents (the SORT OUT III study): a multicentre, open-label, randomised superiority trial
2014
Biolimus-eluting biodegradable polymer-coated stent versus durable polymer-coated sirolimus-eluting stent in unselected patients receiving percutaneous coronary intervention (SORT OUT V): a randomised non-inferiority trial
2013
and 1 more

Author Peers

Author Last Decade Papers Cites
Jens Aarøe 1048 975 571 42 1.4k
Luc Missault 1632 951 189 58 2.1k
Jang‐Ho Bae 1174 879 348 99 2.0k
Akimi Uehata 1345 508 367 70 1.9k
Akihiro Azuma 1209 424 439 105 1.6k
Stefano Meani 1499 265 262 56 1.8k
Rajdeep Khattar 1541 423 469 99 2.0k
John F. Setaro 1421 346 284 44 2.1k
Babeth Rabinowitz 1412 568 650 65 1.9k
Jean-Gilles Latour 1379 612 345 63 2.1k
Andréa Picchi 874 764 354 52 1.9k

All Works

Loading papers...

Rankless by CCL
2026